Search results
Showing results for
Bernard Naughton and Dr David Brindley from Oxford University’s Saïd Business School and Medical Sciences Division discuss the problems of identifying fake, substandard and expired medicines.
In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.
Journal article
Reiné J. et al, (2026), Comput Biol Chem, 122
Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes.
Journal article
Rius R. et al, (2026), Nat Genet
Longitudinal profiles of executive functioning from infancy to 5 years of age-A FinnBrain Birth Cohort Study.
Journal article
Karonen A. et al, (2026), Child Dev
Maternal views on RSV vaccination in the UK's second season.
Journal article
O'Hagan S. et al, (2026), Lancet Infect Dis, 26, e209 - e211
Securing the future of immunisation: ESCMID's vision.
Journal article
Ramasamy MN. et al, (2026), Clin Microbiol Infect, 32, 516 - 518
Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.
Conference paper
Gagnon LL. et al, (2026), Leukemia
Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.
Journal article
Weight CM. et al, (2026), J Infect Dis
Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.
Journal article
Turan G. et al, (2026), Vaccines (Basel), 14
Exploring the ethics of tuberculosis human challenge models.
Journal article
Rohrig A. et al, (2026), J Med Ethics, 52, 251 - 260
Human-specific features of the cerebellum and ZP2-regulated synapse development.
Journal article
Kim S-K. et al, (2026), Cell, 189, 1802 - 1819.e28
Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.
Journal article
Bijukchhe SM. et al, (2026), Lancet Infect Dis
Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.
Journal article
Woffindale C. et al, (2026), Mol Ther Nucleic Acids, 37
Predicting how perturbations reshape cellular trajectories with PerturbGen
Preprint
Chi Hao Ly K. et al, (2026)
Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.
Journal article
Hausdorff WP. et al, (2026), Vaccine, 75
13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.
Journal article
Tembo G. et al, (2026), Vaccine, 75
Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.
Journal article
Cheliotis KS. et al, (2026), Vaccine, 75
Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.
Journal article
González-Martínez I. et al, (2026), Am J Hum Genet, 113, 529 - 547
Targeted BDNF upregulation via upstream open reading frame disruption.
Journal article
Feng N. et al, (2026), Mol Ther, 34, 1652 - 1671
Dosing practices of caffeine therapy for apnoea of prematurity: a retrospective single-centre observational study.
Journal article
Fatunla OAT. et al, (2026), BMJ Paediatr Open, 10